Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial (Q48458394)
Jump to navigation
Jump to search
scientific article published on 4 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial |
scientific article published on 4 April 2012 |
Statements
1 reference
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial (English)
1 reference
Walter Reinisch
1 reference
Edouard Louis
1 reference
Robert Löfberg
1 reference
Anne Camez
1 reference
Mei Yang
1 reference
Paul F Pollack
1 reference
Naijun Chen
1 reference
Jingdong Chao
1 reference
Parvez M Mulani
1 reference
4 April 2012
1 reference
7
1 reference
1
1 reference
34-43
1 reference